These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11399124)

  • 21. Role of interaction between Ly49 inhibitory receptors and cognate MHC I molecules in IL2-induced development of NK cells in murine bone marrow cell cultures.
    Das A; Saxena RK
    Immunol Lett; 2004 Jul; 94(3):209-14. PubMed ID: 15275968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
    J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
    Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
    Sioud M
    Scand J Immunol; 2009 Dec; 70(6):516-25. PubMed ID: 19906192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours.
    Reinis M; Símová J; Indrová M; Bieblová J; Pribylová H; Moravcová S; Jandlová T; Bubeník J
    Int J Oncol; 2007 Apr; 30(4):1011-7. PubMed ID: 17332942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour escape mechanisms and their therapeutic implications in combination tumour therapy.
    Bhutia SK; Mallick SK; Maiti TK
    Cell Biol Int; 2010 Apr; 34(5):553-63. PubMed ID: 20384587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications.
    Hassan HT
    Leuk Res; 2009 Jan; 33(1):5-10. PubMed ID: 18639336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination.
    Cheng WF; Hung CF; Lin KY; Ling M; Juang J; He L; Lin CT; Wu TC
    Gene Ther; 2003 Aug; 10(16):1311-20. PubMed ID: 12883527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new self: MHC-class-I-independent natural-killer-cell self-tolerance.
    Kumar V; McNerney ME
    Nat Rev Immunol; 2005 May; 5(5):363-74. PubMed ID: 15841099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effect of acute and permanent heat shock protein 70 overexpression in tumor cells on lysability by cytotoxic T lymphocytes.
    Dressel R; Grzeszik C; Kreiss M; Lindemann D; Herrmann T; Walter L; Günther E
    Cancer Res; 2003 Dec; 63(23):8212-20. PubMed ID: 14678977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
    del Campo AB; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
    Scand J Immunol; 2009 Aug; 70(2):125-35. PubMed ID: 19630918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylsalicylic acid-induced release of HSP70 from mast cells results in cell activation through TLR pathway.
    Mortaz E; Redegeld FA; Nijkamp FP; Wong HR; Engels F
    Exp Hematol; 2006 Jan; 34(1):8-18. PubMed ID: 16413386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
    Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
    Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
    Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy.
    Bonehill A; Heirman C; Thielemans K
    J Gene Med; 2005 Jun; 7(6):686-95. PubMed ID: 15693037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunobiology of natural killer cells and bone marrow allograft rejection.
    Barao I; Murphy WJ
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):727-41. PubMed ID: 14677112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells.
    Johansson S; Price J; Modo M
    Stem Cells; 2008 Sep; 26(9):2444-54. PubMed ID: 18635871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dynamics of natural killer cell tolerance.
    Johansson MH; Höglund P
    Semin Cancer Biol; 2006 Oct; 16(5):393-403. PubMed ID: 16935000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.